Study Finds High Discontinuation Rates for GLP-1 Weight Loss Drugs
New study by BCBSA reveals 58% of patients discontinue GLP-1 weight loss drugs before seeing benefits. Fitness industry partnerships could help improve adherence and outcomes.
New study by BCBSA reveals 58% of patients discontinue GLP-1 weight loss drugs before seeing benefits. Fitness industry partnerships could help improve adherence and outcomes.